Hypothèses sur les mécanismes d'action de l'amphotéricine B et de ses dérivés dans les encéphalopathies subaiguës spongiformes transmissibles

Medecine/Sciences

Volumn 13, Issue 6-7, 1997, Pages 892-897

  Adjou, K T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744432850     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/481     Document Type: Article

References (32)

1. Büeler H, Fisher M, Lang Y, Bluethmann H, Lipp HP, DeArmond SI, Prusiner SB, Aguet AI, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell surface PrP protein. Nature 1992:356:577-82.
2. Lehmann S. Le rôle de la protéine du prion dans les encéphalopathies spongiformes transmissibles humaines. Med Sei 1996; 12:949-58.
3. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T. Loss of cerebral Purkinje cells in aged mice homozyeous for a disrupted PrP gene. Nature 1996; 380: 528-31.
4. Tobler I, Gaus SE, Deboer T, Ashermann P, Fisher M, Rûlicke T, Moser M, Oesch B, Mcbride PA, Manson JC. Altered circadian activity rythms and sleep in mice devoid of prion protein. Nature 1996; 380: 639-42.
5. DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion diseases Am] rathol 1995; 146:785-811.
6. Bruce ME, Mcbride PA, Farquhar CF. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett 1989; -102: 1-6.
7. Forloni G, Angeretti N, Chiesa E, Mpnzani E, Salmona M, Bugiani O, Taglia\ini F. Neurotoxicity of a prion protein fragment. Nature 1993; 362: 543-6.
8. Forloni G, Del Bo R, Angeretti N, Chiesa E, Smiroldo S, Doni R, Glnbaudi, Salmona M, Porro M, Verga L, Giaccone G, Bugiani O, Tagliavini F. A neurotoxic prion protein fragment induces rat astrosliaf proliferation and hypertrophy. EUT I Neurosri 1994; 6: 1415-142.
9. Paisiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-44.
10. Prusiner SB, DeArmond SJ. Prion diseases and neurodegeneration. Annu Rev Neurosci 1994; 17: 311-39.
11. Ainyx HA, Salazar M, Gajdusek DC, Gibbs CJ. Chemotherapeuuc tnals in experimental slow virus disease. Neurology 1984; 34: 149.
12. Pocchiari M, Schmittinger S, Ladogana A, Masullo C. Effects of Amphotericin B in intracerebrally inoculated hamsters. In : Court LA, Dormont D, Brown P, eds. Unconventional virus diseases of the central nervous system. Fontenay aux Roses: Commissariat à lEnergie Atomique (CEA) Diffusion. 1989: 314-23
13. Pocchiari M, Schmittinger S, Masulo C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters./ Gen \1rol 1987; 68: 219-23.
14. Xi YG, Ingrosso L, Ladogana A, Masullo C, Pocchiari M. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 1992; 306:598-601.
15. McKenzie D, Kacszkowski 1, Marsh R, AikenJ. Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection./ Virol 1994; 68: 7534-6.
16. Saintlulien L, Joly V, Seman M, Carbon C, Yeni P. Activity of MS-8209, a nonester Amphotericin B derivative, in treatment of experimental systemic mycoses. Antimicrob Agents Chemother 1992; 36: 2722-8.
17. Demaimay R, Adjou K, Lasmézas C, Lazarini F, Cherifi K, Seman M, Deslys J-P, Dormont D. Pharmacological studies of a new derivative of Amphotericin B, MS-8209, in mouse and hamster scrapie. / Gen \1rol 1994;75:2499-503.
18. Adjou KT, Demaimay R, Lasmézas C, Deslys J-P, Seman M, Dorrnont D. MS3209, a new Amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie. Antimicrob Agents ChfinotherlWa; 39: 2810-2.
19. Adjou KT, Demaimay R, Lasmézas C, Seman M, Deslys J-P, Dormont D. Differential effects of a new Amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implicaüons for the mechanism of action of potyene anübiotics. Res Wro/1996; 147: 213-8.
20. Kimberlin RH, Walker CA. Characteristics of a short incubation model of scrapie in the golden hamster. / Gen Virol 1977 ; 34 : 295-304.
21. Lasmézas CI, Deslys JP, Demaimay R, Adjou KT, HauwJJ, Dormont D. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. / Gen Virol 1996; 77: 1601-9. K
22. Medoff G, Brajtburg GS, Kobayashi GS, Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Phannacol Toxicol 1983; 23: 303-30.
23. Bowler WA, Oldfield EC. New approches to Amphotericin B administration. Infect Med 1992; 9: 17-23.
24. Szoka FC, Tang M. Amphotericin B formulated in liposomes and lipid based systems. J Liposome Res 1993 ; 3: 363-75.
25. PalaciosJ, Serrano R. Proton permeability induced by polyene antibiotics. A plausible mechanism for their inhibition of maltose fermentation in yeast. FEBS IM 1978 ; 91:198-201.
26. Vertut-Doi A, Ohnishi S, Bolard J. The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic Amphotericin B. Anlimicrob Agents Chemother 1994; 38:2373-9.
27. Carp RI. Scrapie. In Specter S, et al., eds. Neiiropathogenic viruses and immunity. New York: Plenum Press, 1992: 111-36.
28. Taraboulos A, Scott M, Semenov A, Avraham D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOHterminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.yC?//aW1995; 129: 121-32.
29. Shyng SL, Lehmann S, Moulder KL, Harris DA. Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPc, in cultured cells. / Dial Chem 1995; 270: 14793-800.
30. Telling GC, Scott M, MastrianniJ, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. Prion propagation in mice expressing human and cnimeric PrP transgenes implicates the interaction of cellular PrP with another protein. CW/1995; 83: 79-90.
31. Brown P. A therapeutic panorama of the spongiform encephalopathies. Antivir Chem Chemother 1990; 1:75-83.
32. Caughey B. Scrapie associated PrP accumulation and its prevention: insights from cell culture. Br Med Bull 1993; 49: 860-72.